Mean Hematocrit ± SD (%) | P-Value* |
---|
Group
|
Basal
|
Follow-up
|
Δ
|
B vs.
|
C vs.
|
D vs.
|
---|
A: Supportive care
| 26 ± 5 | 21 ± 8 | -5 ± 4 | 0.155 | 0.353 |
0.003
|
B: AT
| 28 ± 9 | 26 ± 9 | -2 ± 7 | | 0.647 | 0.115 |
C: R-TPA
| 32 ± 5 | 28 ± 8 | -4 ± 7 | | | 0.050 |
D: AT + R-TPA
| 27 ± 5 | 29 ± 6 | 2 ± 4 | | | |
- Legend: Δ is the average change of follow-up from baseline. AT: antithrombin III (50 μg/kg bolus, and 25 μg/kg continuous intravenous infusion); R-TPA: recombinant tissue plasminogen activator (0.025 mg/kg/hr); SD: standard deviation. * P-values are based on statistical analysis of the average change from baseline to follow-up for hematocrit (paired t-test).